These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25916523)

  • 1. Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders.
    Martinucci I; Blandizzi C; de Bortoli N; Bellini M; Antonioli L; Tuccori M; Fornai M; Marchi S; Colucci R
    Pharmacogenomics; 2015; 16(5):523-39. PubMed ID: 25916523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological concepts of functional dyspepsia and irritable bowel syndrome future pharmacotherapy.
    Dobrek Ł; Thor PJ
    Acta Pol Pharm; 2009; 66(5):447-60. PubMed ID: 19894640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized medicine in functional gastrointestinal disorders: Understanding pathogenesis to increase diagnostic and treatment efficacy.
    Wang XJ; Camilleri M
    World J Gastroenterol; 2019 Mar; 25(10):1185-1196. PubMed ID: 30886502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics in gastrointestinal disorders.
    Camilleri M; Saito YA
    Methods Mol Biol; 2008; 448():395-412. PubMed ID: 18370239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of pharmacogenetics in gastrointestinal diseases.
    Saito YA; Camilleri M
    Expert Opin Pharmacother; 2006 Oct; 7(14):1857-69. PubMed ID: 17020413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions on early functional gastrointestinal disorders.
    Salvatore S; Barberi S; Borrelli O; Castellazzi A; Di Mauro D; Di Mauro G; Doria M; Francavilla R; Landi M; Martelli A; Miniello VL; Simeone G; Verduci E; Verga C; Zanetti MA; Staiano A;
    Ital J Pediatr; 2016 Jul; 42(1):68. PubMed ID: 27423188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics and the treatment of functional gastrointestinal disorders.
    Halawi H; Camilleri M
    Pharmacogenomics; 2017 Jul; 18(11):1085-1094. PubMed ID: 28686075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics and functional gastrointestinal disorders.
    Camilleri M
    Pharmacogenomics; 2005 Jul; 6(5):491-501. PubMed ID: 16013999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders.
    Manabe N; Wong BS; Camilleri M
    Expert Opin Investig Drugs; 2010 Jun; 19(6):765-75. PubMed ID: 20408739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of neurotransmitter regulators in functional gastrointestinal disorders based on symptom analysis.
    Luo QQ; Chen SL
    J Dig Dis; 2017 Apr; 18(4):203-206. PubMed ID: 28371414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.
    Camilleri M
    Clin Pharmacol Ther; 2012 Jan; 91(1):44-59. PubMed ID: 22071696
    [No Abstract]   [Full Text] [Related]  

  • 12. Contribution of ghrelin to functional gastrointestinal disorders' pathogenesis.
    Koutouratsas T; Kalli T; Karamanolis G; Gazouli M
    World J Gastroenterol; 2019 Feb; 25(5):539-551. PubMed ID: 30774270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyproheptadine: A Potentially Effective Treatment for Functional Gastrointestinal Disorders in Children.
    Krasaelap A; Madani S
    Pediatr Ann; 2017 Mar; 46(3):e120-e125. PubMed ID: 28287686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune dysregulation in the functional gastrointestinal disorders.
    Keely S; Walker MM; Marks E; Talley NJ
    Eur J Clin Invest; 2015 Dec; 45(12):1350-9. PubMed ID: 26444549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional and motility gastrointestinal disorders].
    Mearin F; Rey E; Balboa A
    Gastroenterol Hepatol; 2012 Sep; 35 Suppl 1():3-11. PubMed ID: 23018003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current status and recommendations for pediatric clinical trials in functional gastrointestinal disorders].
    Ding Z; Xu X; Ke M
    Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):567-9. PubMed ID: 25224230
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs acting on serotonin receptors for the treatment of functional GI disorders.
    Tonini M; Pace F
    Dig Dis; 2006; 24(1-2):59-69. PubMed ID: 16699264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The trials and tribulations of drug development for functional gastrointestinal disorders.
    Chang L
    Neurogastroenterol Motil; 2008 May; 20 Suppl 1():130-8. PubMed ID: 18402650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definition and epidemiology of functional gastrointestinal disorders.
    Corazziari E
    Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):613-31. PubMed ID: 15324703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of disease: genetics of functional gastrointestinal disorders--searching the genes that matter.
    Adam B; Liebregts T; Holtmann G
    Nat Clin Pract Gastroenterol Hepatol; 2007 Feb; 4(2):102-10. PubMed ID: 17268545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.